The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients

References

• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:1–5.
   Google Scholar
• Van CE, Lambrechts D, Prenen H, et al. Lessons from the adjuvant bevacizumab trial on colon cancer: what next? J Clin Oncol. 2011;29:1–4.
   Web of Science ®Google Scholar
• Wong R, Cunningham D. Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies. J Clin Oncol. 2008;26:5668–5670.
   Web of Science ®Google Scholar
• Asghar U, Hawkes E, Cunningham D. Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer. Clin Colorectal Cancer. 2010;9:274–281.
   PubMed Web of Science ®Google Scholar
• Staib L, Link KH, Blatz A, et al. Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients–monoinstitutional experience. World J Surg. 2002;26:59–66.
   PubMed Web of Science ®Google Scholar
• Young A, Rea D. ABC of colorectal cancer: treatment of advanced disease. Bmj. 2000;321:1278–1281.
   PubMedGoogle Scholar
• Christopoulou A. Chemotherapy in metastatic colorectal cancer. Tech Coloproctol. 2004;8(Suppl S1):s43–s46.
   Google Scholar
• Folkman J. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. Cancer Metastasis Rev. 1990;9:171–174.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364.
   PubMed Web of Science ®Google Scholar
• Reinmuth N, Parikh AA, Ahmad SA, et al. Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech. 2003;60:199–207.
   PubMed Web of Science ®Google Scholar
• Ellis LM. A targeted approach for antiangiogenic therapy of metastatic human colon cancer. Am Surg. 2003;69:3–10.
   PubMed Web of Science ®Google Scholar
• Guba M, Seeliger H, Kleespies A, et al. Vascular endothelial growth factor in colorectal cancer. Int J Colorectal Dis. 2004;19:510–517.
   PubMed Web of Science ®Google Scholar
• Lee JC, Chow NH, Wang ST, et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer. 2000;36:748–753.
   PubMed Web of Science ®Google Scholar
• Bendardaf R, Lamlum H, Ristamäki R, et al. Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer. Tumour Biol. 2007;28:212–220.
   Google Scholar
• Kondo Y, Arii S, Furutani M, et al. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. Cancer. 2000;88:1820–1827.
   PubMed Web of Science ®Google Scholar
• Tokunaga T, Oshika Y, Abe Y, et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer. 1998;77:998–1002.
   PubMed Web of Science ®Google Scholar
• Liu J, Duan Y, Cheng X, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun. 2011;407:348–354.
   PubMed Web of Science ®Google Scholar
• Martins SF, Garcia EA, Luz MA, et al. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer. Cancer Genomics Proteomics. 2013;10:55–67.
   PubMed Web of Science ®Google Scholar
• Des GG, Uzzan B, Nicolas P, et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer. 2006;94:1823–1832.
   Web of Science ®Google Scholar
• Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist. 2000;5(Suppl 1):37–44.
   PubMedGoogle Scholar
• Bayhan Z, Simşek T, Ergül E, et al. Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene polymorphism. Hepatogastroenterology. 2014;61:1889–1894.
   PubMedGoogle Scholar
• Kwon KA, Kim SH, Oh SY, et al. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer. 2010;10:203.
   PubMed Web of Science ®Google Scholar
• Ishigami SI, Arii S, Furutani M, et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer. 1998;78:1379–1384.
   PubMed Web of Science ®Google Scholar
• Akagi K, Ikeda Y, Miyazaki M, et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer. 2000;83:887–891.
   PubMed Web of Science ®Google Scholar
• White JD, Hewett PW, Kosuge D, et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res. 2002;62:1669–1675.
   PubMed Web of Science ®Google Scholar
• Ogata Y, Matono K, Mizobe T, et al. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. Oncol Rep. 2006;15:1111–1116.
   Web of Science ®Google Scholar
• Jalbă CS, Jalbă BA, Nicula C, et al. Clinical relevance of vascular endothelial growth factor-A in colorectal cancer. Rom J Morphol Embryol. 2011;52:775–781.
   Web of Science ®Google Scholar
• Pohl M, Werner N, Munding J, et al. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature. Z Gastroenterol. 2011;49:1398–1406.
   PubMed Web of Science ®Google Scholar